Based in the United States, EVQLV is a startup.
EVQLV develops a proprietary computational platform that accelerates the discovery and design of fully-human antibodies using machine learning and computational biology techniques.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.